Association between F508 deletion in CFTR and chronic pancreatitis risk

Abstract Background The cystic fibrosis transmembrane conductance regulator ( CFTR ) has been reported to influence individual susceptibility to chronic pancreatitis (CP), but the results of previous studies are controversial. Aims We performed a study to demonstrate the relationship between CFTR and CP. Methods We searched PubMed, Scopus, and Embase for studies of patients with CP. Seven studies from 1995 to 2016 were identified, and included 64,832 patients. Pooled prevalence and 95% confidence intervals (CIs) were calculated. Results F508 deletion in CFTR was significantly positively associated with CP risk in the overall analysis (odds ratio [OR] = 3.20, 95% CI: 2.30–4.44, I 2  = 31.7%). In subgroup analysis stratified by ethnicity, F508 deletion was significantly associated with CP risk in Indian populations, using a fixed effects model (ORs = 5.45, 95% CI: 2.52–11.79, I 2  = 0.0%), and in non-Indian populations, using a random effects model (ORs = 3.59, 95% CI: 1.73–7.48, I 2  = 60.9%). At the same time, we found that Indians with F508 deletion had much higher CP prevalence than non-Indians. Interestingly, F508 deletion was also associated with CP and idiopathic CP risk in subgroup analysis stratified by aeitiology, using the fixed effects model. Conclusions Based on current evidence, F508 deletion is a risk factor for CP, and Indians with F508 deletion have much higher CP morbidity.